A Doctor’s View on Healthcare Reform

April 30, 2009

Time magazine’s Scott Haig, M.D., says in a recent article that to fix healthcare we need to streamline regulation and billing, “computerize everything,” and find a better way of sanctioning bad practices without the threat of malpractice litigation.

On managed care, he writes: “It costs the typical doctor about 10%, right off the top, to collect our fees from the HMOs and other insurance companies we have to deal with.  This is due to the ultra-complex set of rules and regulations those companies have established to ‘control costs’ (read: to pay us less while their executives take home more) and the billing staffs we have to hire to deal with them. This money does nothing for patients….It could easily be eliminated with simple, intelligent, centralized payment rules.”

I always wondered what was up with all those workers shuffling papers in my doctor’s office.


Aetna 1Q09 Financials: So Much for the Good News

April 29, 2009

The generally favorable first-quarter results posted by WellPoint and UnitedHealth earlier this month (see prior post) had us thinking the managed care industry had turned the corner.  All right, we still think that’s true in general.  But Aetna’s first quarter results sure didn’t help the cause. 

The big problem was higher-than-expected medical costs in the company’s commercial line.  Whenever costs at a health plan come in higher-than-expected, Wall Street freaks out.  Not surprisingly, shares in Aetna are down 9% this morning.

We’ll do our usual detailed take on Aetna’s results in the next issue of Managed Healthcare Market Report.  Right now, I’d just like to note some of the reasons Aetna gave for the unexpected spike in medical costs.

1. People who are afraid of losing their jobs (and health insurance) are rushing to get treatments and medical services.

2. People who have already lost their jobs, but have a severance package with benefits, are rushing to get treatments and medical services before the severance package ends.

3. People informed their company will be reducing benefits (e.g., Aetna is seeing benefit buydowns in the 150 to 200 basis point range) are rushing to get treatments and medical services.

4. People who sign up for Cobra after losing their jobs typically have higher medical costs than non-Cobra members.

When asked if the company should have seen all this coming, Aetna chief executive Ron Williams responded on a conference call with Wall Street analysts that 2009 is unlike any other year the company has experienced.  “Some things we obviously didn’t anticipate,” he said.

Aetna had originally expected 2009 medical costs to rise 7.5% to 8.5%.  The company is now saying there’s “upward pressure” on that range.  Meanwhile, the company is maintaining its profit forecasts for the year, with officials noting that it has already adjusted pricing to reflect cost pressures. 

Wall Street will be watching…and worrying.


The Annals of Unintended Consequences, Part 2: Medicare Advantage Cuts

April 28, 2009

Oppenheimer analyst Carl McDonald writes: “Even though the Medicare Advantage program enrolls a disproportionate number of low income and minority beneficiaries (two key Democratic constituencies), the new Administration is essentially telling these seniors that although they are some of the most vulnerable members of society, they have been receiving too much welfare over the past few years, and that it is going to be taken away, in the form of higher premiums and reduced benefits. It is one thing to take something away from a wealthy individual that can afford to give it up, but quite another to take it from an elderly grandmother just scraping by.
 
“We’re not suggesting that all Medicare Advantage beneficiaries are low income or minority, or even that most are, but it feels to us like the Democrats in Congress that are up for re-election in 2010 still don’t seem to appreciate the pushback they are going to get later this year when 11 million seniors realize their out of pocket cost sharing is going way up. Because of how quickly the benefit changes are happening relative to the Democrats taking power, it is going to be very easy for the media to blame the new Administration as the cause for the change.”


The Annals of Unintended Consequences: Bicycle Helmet Laws

April 28, 2009

The Social Science Research Network has published a paper titled “Evaluating the Health Benefit of Bicycle Helmet Laws,” by Piet De Jong, suggesting that bicycle helmet laws “are counterproductive in terms of net health.”  (Hat tip Infectious Greed)

From the abstract: “A model is developed which permits the quantitative evaluation of the benefit of bicycle helmet laws. The efficacy of the law is evaluated in terms of the percentage drop in bicycling, the percentage increase in the cost of an accident when not wearing a helmet, and a quantity here called the ‘bicycling beta.’  The approach balances the health benefits of increased safety against the health costs due to decreased cycling. Using estimates suggested in the literature of the health benefits of cycling, accident rates and reductions in cycling, suggest helmets laws are counterproductive in terms of net health.”


4 Signs Obama’s Public Health Plan Proposal Is in Trouble

April 27, 2009

Here are four signs that President Obama’s proposal for a government-run health plan for the uninsured and small business is in trouble. 

1. Baucus says the public plan is “a bit on the side of the table.”  Senate Finance Committee Chairman Max Baucus (D-MT) made the comment in a meeting on Friday with reporters.  Writes Congressional Quarterly: “Instead, he said, he would focus on preserving the insurance system for self-insured companies while expanding private insurance and public programs such as Medicaid….He later backed off that statement slightly, saying he might return to the government-run idea later on.”

2. DeParle talks compromise.  In a press conference earlier this month (see our prior post), White House healthcare czar Nancy-Ann DeParle reiterated that Obama’s support for the public plan is aimed at keeping costs low, keeping insurers honest, and offering consumers choice.  “But as he said, if there are other ways of doing that, he’d be open to talking about them,” she noted. 

3. Hacker comes out swinging to defend the public plan.  The public plan has been the signature concept of Jacob Hacker, co-director of the Center for Health, Economic and Family Security at U.C. Berkeley.  Hacker slammed The Lewin Group earlier this month for projecting that 118 million people might switch from private plans to the proposed public plan (In fairness, Lewin offered a range of projections starting as low as 10 million, based on different public plan scenarios).  Then he shot down a compromise proposal by Len Nichols and John Bertko, in which the public plan would have limited bargaining power.   I’m not saying Hacker is wrong (in fact, I like his plan and have endorsed the public plan concept in general).  I just give Lewin’s recent projections a little more credit than Hacker does—granted, nowhere near the 118 million level, but not nothing either.   All of which makes me wonder if Hacker is feeling a tad jittery about the fate of his pet proposal.   

4. Idle conversation.  In an informal conversation earlier this month with a Washington policy wonk who is also a vocal supporter of the public plan, I said, “It looks like the public plan is going to happen.”  She arched her eyebrows and said, “Really?”


Leavitt Slams Obama’s Public Health Plan Proposal

April 27, 2009

Writing on the conservative blog AmericaSpeakOn.org, former Secretary of Health and Human Services Michael Leavitt slammed President Obama’s proposal for a government-run health plan.  Writes Leavitt:

“President Obama supports the idea of a ‘public option’ for health insurance.  The language of competition and choice cleverly conceals the objective.  But the President’s ‘public option’ is a gateway leading to 118 million Americans losing the option of private choice.  It is a strategy for government-run health care.  It is a Trojan horse….

“There is another answer.  The government needs to promote value—to empower consumers to pursue the highest-quality care at the lowest-possible prices.  Strong government action is needed to organize an efficient market where consumers can choose insurance plans and medical practitioners who offer the best value.  What is not needed is to replace the private market with a government-run system in which only the truly rich have a choice.”


Is ‘Outcomes Guarantee’ Here to Stay?

April 27, 2009

It seems that ”outcomes guarantees” with drugs are beginning to take hold in medical practice. Merck, in a deal with Cigna, agreed to charge for its diabetes drugs depending on how well patients fare.  Procter & Gamble will apparently pay Health Alliance for treating bone fractures in patients who took Actonel for osteoporosis, and the drug failed to prevent the fracture.

These sorts of agreements have been used in some European countries, but pharmaceutical companies are likely to make such deals with only certain types of drugs.  In the Merck example, the drugs chosen (Januvia and Janumet) are fairly effective, so most patients are likely to experience improved control, assuming they take their medicines regularly, something that the insurers will try diligently to enforce.

In the case of Actonel, the rate of fractures is low enough—and the competition is fierce and includes more effective drugs than Actonel (including generics)—that this deal looks like an excellent marketing move.  We don’t know the details of the agreements (e.g., what kind of discount is Merck giving or what proportion of fracture cost is P&G going to cover), but this trend is likely to continue for selective drugs in highly competitive markets—the real effective ones and the less effective ones with low sales.  Ineffective drugs that sell well will probably lose in the market place, which is exactly the way it should be.  All in all, I view these as a win/win situation for the companies. Time will tell if they also turn out to be a good deal for the patients.


6 in 10 Put Off Healthcare Because of Costs

April 24, 2009

A new survey from the Kaiser Family Foundation found that six in 10 Americans say they or a member of their household have delayed or skipped healthcare in the past year. 

Kaiser reports: “The most common actions taken due to costs were substituting home remedies or over-the-counter drugs for doctors visits (42%) and skipping dental care or check ups (36%).  Additionally, three in ten (29%) did not fill a prescription for medicine and two in ten (18%) cut pills in half or skipped doses.

Kaiser also found that “a solid majority of the public (59%) believes health care reform is more important than ever compared with the thirty-seven percent who say we can’t afford health reform because of economic problems.”


The Politics of Healthcare Reform

April 24, 2009

Gerald Seib of The Wall Street Journal talks in this video about efforts among some Democrats and Republicans to reach a compromise on healthcare reform.


Healthcare Reform Ironies—Part II: Selling Your Side

April 24, 2009

It’s interesting to see how the left has co-opted the language of conservatives by arguing that a public health plan would be good for competition.  Writes Alexander Hertel of the Economic Policy Institute:

“Far too much of our health care system is characterized by limited or non-existent competition, both in the market for insurers as well as the market for providers. This lack of competition is a major source of the United States’ uniquely high and rising health costs. A public plan option would force private insurers to compete on efficiency and quality, rather than on their ability to enroll the lowest-cost workers and firms. Furthermore, a public plan would introduce competition to currently monopolistic or oligopolistic insurer and provider markets—three or fewer insurers account for at least 65% of market share in 36 states. The situation is even worse in markets for small businesses, where a single insurer in each state generally controls half of the market for health insurance coverage. Further,  consolidation of health care provider (especially hospital) markets has also limited insurers’ ability to competitively bargain for lower rates. The presence of a heavily concentrated provider market can increase prices for the same treatment by 40%  or more. The public plan would guarantee competition even in these consolidated markets, leveraging its size and efficiencies to bargain for the most efficient rates with health care providers.”

The health insurance industry, meanwhile, seems to be arguing that the reason we can’t have a public plan is that it would be too successful.

Got irony?  Send along your favorites.


A World of Healthcare Reform: Lessons from the Swiss and Dutch

April 23, 2009

Here’s some interesting views on healthcare reform, which I think provide a helpful perspective on the current U.S. debate.

The first is from a November 2007 article by Maggie Mahar (hat tip to Matthew Holt at TheHealthcareBlog), which talks about how the Swiss have achieved a workable universal healthcare system involving private insurance. 

Writes Mahar:  “Swiss patients have relatively little say over either the cost or the quality of the care they receive. Prices are regulated by the government, which also tries to make sure that consumers are getting value for their health care dollars by selecting which drugs, devices and tests insurance will cover. In fact, it is the very visible hand of a smart, largely efficient government that accounts for Switzerland’s relative success.”

She goes onto cite research from Ewe Reinhardt, suggesting that “Because insurers are so strictly regulated, consumers have fewer options. They can’t pick a bargain-basement plan that is less than comprehensive; it doesn’t exist. Cheap plans with a $10,000 deductible per family member also are not available; the government sets a mandated minimum and ceiling for deductibles. And households cannot choose between plans that offer high co-pays or no co-pays.”

The second is from a recent research note by Leerink Swan equity analyst Jason Gurda, which talks about the effects of healthcare reform in The Netherlands in 2006.

Writes Gurda: “The introduction of universal coverage in the Netherlands has been a negative for the health insurance industry thus far. Standardized benefits and the inability to reject applicants left premium pricing as the primary means of insurer competition. A grab for market share led to below cost premium pricing and operating losses for insurers, although consolidation appears to be leading to improvement.

“Under the old system, the Dutch health insurance system consisted primarily of two groups: 1) a socialized health insurance system for people in lower income brackets; and 2) voluntary private health insurance for people with higher incomes.

“Beginning in 2006, all Dutch citizens have been required to buy standardized individual health insurance coverage from a private insurer.

“Individuals can shop for insurance using a government web site which compares health insurers with respect to price, services, consumer satisfaction, supplemental insurance, and available hospitals. Individuals may also pay extra for supplemental insurance for benefits that are not included in the mandatory basic insurance package, such as dental care, physiotherapy, eyeglasses, alternative medicine, and cosmetic surgery.”

In lieu of going single-payer or totally free market, a reformed U.S. system will for now have to cope with striking a precarious balance between the two.  And when you come right down it it, that’s really not news.


United, WellPoint Set Stage for 1Q09 Earnings Season

April 22, 2009

There were a lot of similarities in the first-quarter 2009 earnings results for UnitedHealth Group and WellPoint, the first of the major managed care organizations to release results for the quarter.

Both reported a decline in net income.  Both reported an increase in earnings per share (tied to a drop in diluted shares outstanding).  Both easily beat Wall Street expectations.  Both saw a decline in fully funded membership. 

Generally speaking, I think you’d have to conclude the results were good (although the initial Wall Street reaction was mixed)—and that’s good news for managed care companies in general as they attempt to price their way out of last year’s underwriting downcycle.

One broader, nagging concern is the continued drop in fully funded membership. 

WellPoint’s fully funded lives fell 3.7% in the quarter, compared to a year earlier year-end 2008, a faster rate of decline than the company had expected.  United’s commercial risk business fell 4.3%, slightly better than expected. 

No doubt, the struggling economy was a big factor, but as an industry-wide trend, fully funded enrollment has been under pressure for some time. 

Meanwhile, there were lots of questions from Wall Street analysts on  WellPoint’s earnings conference call about the impact of consumer-directed business on the company’s medical cost ratio.

WellPoint’s MCR improved 350 basis points to 81.6% in the quarter, but the company expects its MCR to deteriorate through the year as CDHP members hit their deductibles and benefits kick in.  Still, the big improvement raises the possibility that profits will come in better-than-expected for the year.

Joshua Raskin of Barclays Capital basically summed up the Street’s confusion, noting even though WellPoint’s CDHP membership rose 14% to 2 million, “I can’t understand how that’s a 350 basis point impact” on the MCR. 

The question relates to the seasonality of CDHPs.  You’ll recall a couple of years back when United failed to adequately forecast the fact that high-deductible health plan costs tend to soar late in the year when members rush to get treatment before the deductible resets for the next year.

WellPoint officials on the call indicated that they were leaving a lot of room for error through 2009, not just in projecting CDHP costs, but also in forecasting the impact of the economy on business overall.

All of which suggests that the health insurance industry is dealing with an array of short-term and long-term issues: among them, learning how to forecast CDHP business, assessing the impact of a down economy, navigating what appears to be the tail-end of an underwriting downcycle, and stressing out over Obama’s healthcare reform goals.

Here’s another: Couple the growth in low-premium CDHPs with an overall decline in risk business, and you’ve got the potential for some long-term pain in health plan profitability.  No wonder investors are wary.


Healthcare Debate Heats Up

April 20, 2009

As promised, here’s some additional video coverage from the World Health Care Congress, April 14-16, Washington, DC.  As this report shows, the healthcare reform debate is heating up, and one area of contention remains a proposed public health plan that would compete with the private insurance industry.  With comments from Angela Braly of WellPoint and Jeffrey Kang, M.D., of Cigna.


Not-For-Profit BCBS Plans Feel the Pinch

April 20, 2009

Not-for-profit Blue Cross Blue Shield plans felt the pinch in 2008, with capital levels hammered by falling investment income, writes Carl McDonald of Oppenheimer.  The result: BCBS plans are raising prices.  Notes McDonald:

“With capital at the Blues having fallen to levels last seen in 2003/2004, pricing has firmed, creating a floor on pricing in many markets for the publicly traded commercial plans.

“There is ample evidence that the Blues are raising prices by more in 2009, but the full impact of the significant equity market decline probably wasn’t recognized in January 1 renewals, since many plans had released rates before the market got really bad in the fourth quarter. This means that pricing will likely strengthen over the course of the year….

“Underwriting margins for the Blues were stable in 2008, at 1.3%, as the medical loss ratio for the Blues deteriorated just 30 basis points, to 86.7%. Risk enrollment at the Blues fell by about 1 million lives in 2008, by our estimate. The excess capital held by the Blues fell by $4.5 billion, a drop of almost 20%….

“In total, our analysis tracks 33 non-profit Blues that generated $135 billion in revenue in 2008, and covered a total of 44.3 million risk lives.”


$1.1 billion for Comparing Drugs: A good idea?

April 20, 2009

Three federal agencies (HHS, NIH, AHRQ) received $1.1 billion (as part of the stimulus plan) to perform comparative studies on the effectiveness of medical treatments such as drugs and devices.  This is another chapter in the ongoing  debate between free-market and government-control advocates.

In the free-market, better drugs should be prescribed more often and ineffective drugs should not get approved, and if approved, should go unused. (Incidentally, some ineffective drugs can get approved because of the archaic rule of the FDA that requires positive results in two well-controlled clinical trials, irrespective of the number of negative trials (e.g. 2 positive and 4 negative trials will still get your drug approved).

To the degree that free markets have not resolved this issue neatly, we have three factors to blame: 1.The hype and advertising, coupled with physicians’ participation in both, give the edge to the better publicized drug, not to the objectively better drug.  2. The differences between drugs are often too small to be meaningful. 3. The makers of the drugs hardly ever conduct comparator studies, mostly because they see no reason to risk an outcome unfavorable to their drug.  (Another reason that companies don’t perform such studies is that to show small advantages requires very large and expensive trials).

Which brings us to the major problem with this new initiative: comparing “effectiveness” of drugs is not as simple as it sounds.  Some advantages could be subtle but important (once a day versus twice a day), subtle but less important (fewer drug interactions) or balanced by an undesired effects (better efficacy but more nausea, for example).  I suppose one can think of some situations where studies can be useful (e.g., where collective experience suggests that a drug is indeed inferior, but there is no formal evidence), but at the end this could all be a fool’s errand.  The concern of the opposition to these studies is that the “inferior” drug will not be covered by insurance, but if the information is not acted upon, why get it?

On balance, the money could be much better spent on other things—for example, as I have commented before, on driving innovation in small biotech companies.


More on the Public vs. Private Insurance Debate

April 17, 2009

Here’s a very good video report from Bertha Coombs of CNBC on the healthcare reform debate over a public plan that would compete with private health insurers, including comments from Angela Braly of WellPoint and Ed Hanway of Cigna.  Even better is the subsequent point-counterpoint between former Medicare head Kerry Weems and Center for American Progress senior fellow Judy Feder.  I don’t agree with Weems, but I feel for him.  Arguing against Feder is like arguing against your kindly grandma.


Cost Still the Real Issue in Healthcare Reform

April 17, 2009

I’ve been wanting to write (again) about the seemingly forgotten issue of cost as the major barrier to healthcare reform, i.e., how do we pay for it.  Cost is the reason Carl McDonald of Oppenheimer—my regular guest on Healthcare Week in Review—thinks healthcare reform is still a long shot (see video).  Luckily for me, I don’t have to spend this Friday writing about the cost issue because Jonathan Cohn of The New Republic already covered it pretty well in this post from January.  Cohn writes:

“President Obama, in his budget outline, put forward two ideas for raising this money. One was a reduction in the income tax deductions upper-income Americans take for charitable contributions. The other was reforms to the health care system itself, including elimination of the excessive payments government makes to some private insurers participating in Medicare. 

“But that only amounted to $634 billion, or around half (maybe less) of what it will take to get to full coverage….[Senate Finance Committee Chairman Max] Baucus has raised some alternatives.  And, as I (among others) have written before, the best source of funds may be the existing exclusion of employer health benefits from personal income taxes….But changing the exclusion invites strong political opposition….

“We could, of course, simply increase taxes on personal income–or impose a value-added tax, as many European nations have. We could enact a cap-and-trade scheme, then channel some of the revenue into health care, or we could cut spending elsewhere. But these measures would be no easier to accomplish politically.

“And that’s the rub. At this point, financing health care reform isn’t much of a policy challenge.  There are plenty of options, many of them both progressive and economically sound.  But it’s a huge political challenge.”

Agreed.


DeParle on Public Plan Compromise

April 17, 2009

Here’s a video of healthcare czar Nancy-Ann DeParle at a Kaiser Family Foundation forum in which she points to the possibility of a compromise on a public health plan for the uninsured and small business—a plan that would compete side-by-side with private insurance through a national health insurance exchange. 

But she wouldn’t say outright during a Q&A with reporters that President Obama would sign reform legislation that didn’t include a public plan. 

Stephen Langel, Roll Call: “If the President was presented with legislation that had no public plan option, if that was what he needed to take to sign a bill into law, would he be willing to do it?”

DeParle: “Again, I’d answer this the way the President did, which is that he has a couple of goals when he put the public plan in….He wanted to make sure that he could keep costs low, and the public plan is one way of doing that, and he wanted to make sure there was competition and choice for consumers…But as he said, if there are other ways of doing that, he’d be open to talking about them.”

The health insurance industry opposes the public plan, fearing it would steal away business and shift costs to the private sector.  A public plan could use the government’s bargaining power to drive down payments to providers (i.e., pay Medicare rates) and offer more attractive premiums. 

“There are policy ways of getting around some of the objections,” DeParle said.  “You don’t have to use Medicare prices, you can use something else….Now if it’s a philosophical disagreement, ‘I just don’t want the government offering a plan,’ that’s a different thing.”

Far be it from me to imply that a ”philosophical disagreement” over big government versus the free market has stood in the way of meaningful healthcare reform in the past.  But let’s try to be optimistic. 

By using market rates to pay providers (as opposed to Medicare rates), the public plan would lose a key competitive advantage.  That would protect the health insurance industry, but it would also mean higher costs for plans participating in the exchange.

Another option (which DeParle didn’t mention) is to let the government set payment rates, and then let private plans use those same rates.  There would still be a risk of cost-shifting to the private sector, but presumably there would also be an offset: universal coverage means less uncompensated care given by providers.

If I had to choose, I’d probably go with the latter compromise.  The public plan would still have the advantage of lower administrative costs, and the private plans could use payment savings to innovate around benefit design and care management.

It’s all getting very interesting, and very complicated.


Hacker Rips Lewin Group on Public Plan Membership Estimates

April 16, 2009

Here’s an interesting post titled “The End of Private Health Insurance. Not.by Jacob Hacker, who rips The Lewin Group’s estimates that a public health plan option would result in private plans losing a significant chunk of membership.  There’s an extended technical discussion by Hacker here.  I spoke to a representative from Lewin earlier this week, and he defended the estimates.  More on all this in a later post.


D.C. Daze

April 15, 2009

I’m in Washington, D.C., for the World Health Care Congress so no post today.  I will say that a lot of the talk here concerns the debate over Obama’s plan to include a government-run health insurance option for the uninsured and small business as part of an overall healthcare reform package.  More later.


Alternatives to Drugs?

April 14, 2009

The recent economic downturn has led to a decrease in prescription fillings by patients and increased use of vitamins and other supplements.  The latter phenomenon is also the result of growing healthy skepticism (no pun intended) about the safety and efficacy of many branded drugs.  Of course, this trend is frowned upon by the medical establishment and the pharmaceutical industry but to me this is quite logical. Frankly, there are many supplements that have favorable medical effects, especially for less serious conditions and for prevention.  Vitamin and mineral deficiencies are not rare, especially in those with less healthy eating habits and life styles.  The example of the high prevalence of vitamin D deficiency among elderly people seems to be well documented, as the many benefits of vitamin D are being discovered. The challenge to the consumer is keeping clear of the many unscrupulous vendors in the market, but the shift to more supplement use is here to stay.  It is time for the government and the private sector to engage in a more serious review of nutraceuticals so as to offer cogent guidelines to people.  More regulation– provided it is reasonable–may be helpful in bringing the supplement industry to the mainstream, where I think it belongs.


‘Healthy Competition,’ Hacker-Style

April 13, 2009

Healthcare policy wonk Jacob Hacker took to the stump last week to defend his proposal—favored by President Obama, panned by health insurers—to offer a government-run health plan option to the uninsured and small business.

He took an interesting tack, as evidenced in the title of his policy brief: “Healthy Competition, How to Structure Public Health Insurance Plan Choice to Ensure Risk-Sharing, Cost Control, and Quality Improvement.”

Hacker sees the public plan competing on a level playing field with private plans, resulting in lower costs and improved efficiencies for both.

While a public plan’s strengths would include stability, wide pooling of risk and affordable premiums, Hacker notes, “private plans are generally more flexible” and can serve as a source for innovation in benefit design and care management.

“If the public plan becomes too rigid, for example, more Americans will opt for private plans.  If private plans engage in practices that obstruct access to needed care and undermine health security, then the public plan will offer a ready release valve,” he writes.

Hacker may be sincere in this view, and he may even be right.  But that can’t be too reassuring to the health insurance industry, which stands to lose a huge chunk of membership to the public option—some 30 million to 100 million members, according to one study

The key for Hacker is that the public plan, which would be offered along side private plans in a national insurance exchange, must have the ability to use its bargaining power to drive down costs.  He shot down as “flawed” and a “serious mistake” a compromise proposed last month by Len Nichols and John Bertko, in which the public plan would have limited bargaining power. 

To level the playing field, both the public and private plans available through the exchange would offer community rating, guaranteed issue and standardized benefit design.  In addition, payments to the public and private plans would be risk adjusted and pricing would vary to reflect regional cost differences. 

All of which would still result in premiums for the public option estimated at up to 30% lower than private plans.  That health plans will need to drive innovation to survive in this environment is altogether true.  But private insurers will also need to recognize that under this proposal their industry will be smaller, perhaps by a lot.


WellPoint To Sell PBM, Redefines ‘Integrated’

April 13, 2009

I found it interesting that in WellPoint’s press release announcing an agreement to sell its pharmacy benefit management unit to Express Scripts for $4.7 billion, WellPoint chief executive Angela Braly used the word “integrated” three times.

The deal will “improve our integrated health benefits offerings,” she said, adding that “WellPoint continues to be an industry leader in providing integrated medical and pharmacy benefits.”  And for good measure, she said, the deal will “strengthen and accelerate our ability to execute on our integrated health benefits model.”

O.K., I thought “integrated” referred to owning and operating complimentary businesses.  So if you’re a health plan and you own a PBM, then you can offer integrated medical and drug benefits. 

Or, you can job out mail order drug distribution and back office functions like claims processing, but still claim to be integrated by retaining key functions such as formulary management.

WellPoint will indeed maintain formulary management, medical policy and integrated disease management functions.  Express Scripts will take over pretty much everything else, including mail order drug distribution, claims processing and negotiating with drug makers under a 10-year contract.  

The price tag, at $4.7 billion, appears to be a good one from WellPoint’s perspective.  And as expected, the announcement boosted WellPoint’s share price (up nearly 6% in early trading Monday morning).  Of the $3.3 billion WellPoint will receive in cash (the rest in Express stock), it will use $2 billion to repurchase shares—something investors have clamored for.

I’d said in a prior post that if WellPoint sold its PBM the deal would be mostly about boosting its stock price.  By retaining some key functions it can still sing the “integrated” song.  Meanwhile, standalone PBMs like Express can point to the deal as proof that health plans should carve out rather than integrate drug benefits. 

Finally, the price tag (and jolt to WellPoint’s share price) may just be sweet enough to induce other health plans to consider the sale of their PBM units.  These things tend to come in waves.


Premiums and Profits at Health Plans

April 10, 2009

There are a lot of interesting bits in the paper released this week by healthcare policy wonk Jacob Hacker—he of the government-run health plan proposal favored by President Obama for the uninsured and small business.  Hacker had a lot to say in defense of his proposal in the face of competing plans and potential compromises.  I’ll get into all that in another post.  I just wanted to highlight here one interesting and often overlooked point: Rising premiums mean rising profits for health plans. 

Hacker writes: “Private insurers can often save more by selecting healthy people than by bargaining with providers, and in some highly concentrated insurance markets, private insurers are effectively acting as oligopolies, keeping premiums high rather than driving hard bargains….Private plans are passing on rising costs to subscribers while increasing their profitability.”

I wrote about how we got to this point in an opinion piece back in September 2007, pointing out that little being proposed by the health insurance industry at the time would dramatically alter premium and cost increases that had settled into a fairly predictable 6-8% range: “Not health savings accounts, not retail health clinics, not wellness or disease management programs.  Nor is it clear that managed care plans really want to see a substantial moderation in premium trends—despite their rhetoric—with hefty rate hikes closely tied to the kind of strong profit growth health plans have enjoyed in recent years.”

One of my favorite quotes from Upton Sinclair is appropriate here: “It is difficult to get a man to understand something, when his salary depends upon his not understanding it.”


Healthcare and Income Disparity

April 9, 2009

Not all-that surprising findings from McKinsey on how healthcare costs contribute to income disparity in the U.S.:

“The top-income category (earning on average $210,100 annually) has enjoyed rising incomes and growing employer-paid health care benefits, which have made their out-of-pocket spending on health care a relatively small and affordable portion of total spending. The higher-middle-income category (earning an average of $84,800 annually) and the lower-middle-income group (earning on average $41,500), have also seen increasing benefits and incomes—but at a much slower rate, making the uncovered portion of their health care costs ever-more expensive. In the bottom-income category (earning an average of $14,800 a year), incomes have been stagnant, and their employers are less likely to pay for their health insurance. This group is finding any health care difficult, if not impossible, to afford.”


Follow

Get every new post delivered to your Inbox.

%d bloggers like this: